We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMOD.L Regulatory News (MOD)

  • There is currently no data for MOD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appendix 3B

27 Feb 2019 09:41

RNS Number : 2729R
MOD Resources Limited
27 February 2019
 

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

 

Appendix 3B

 

New issue announcement,

application for quotation of additional securities

and agreement

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

 

Name of entity

MOD Resources Limited

 

ARBN

78 003 103 544

 

We (the entity) give ASX the following information.

 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

1

+Class of +securities issued or to be issued

 

Fully Paid Ordinary Shares

 

2

Number of +securities issued or to be issued (if known) or maximum number which may be issued

 

21,353,317 Fully Paid Ordinary Shares

 

 

3

Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

Fully Paid Ordinary Shares

 

 

4

Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

 

If the additional +securities do not rank equally, please state:

· the date from which they do

· the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

· the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

Yes, the shares will rank equally with ordinary share currently on issue.

 

5

Issue price or consideration

 

$0.24 per share

 

 

 

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

 

Issue of shares pursuant to the non-renounceable Entitlement Offer announced on 21 January 2019

 

 

 

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

 

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

Yes

 

 

6b

The date the security holder resolution under rule 7.1A was passed

30 May 2018

 

 

6c

Number of +securities issued without security holder approval under rule 7.1

N/A

 

 

 

6d

Number of +securities issued with security holder approval under rule 7.1A

N/A

 

 

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

 

N/A

 

 

6f

Number of +securities issued under an exception in rule 7.2

21,353,317 Fully Paid Ordinary Shares

 

 

6g

If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation.

N/A

 

 

6h

If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

N/A

 

 

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

Refer Annexure 1

 

7

+Issue dates

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

27 February 2019

 

 

 

Number

+Class

8

Number and +class of all +securities quoted on ASX (including the +securities in section 2 if applicable)

303,682,339

 

Fully Paid Ordinary shares

 

 

Number

+Class

9

 

 

 

 

 

 

 

 

 

 

 

 

Number and +class of all +securities not quoted on ASX (including the +securities in section 2 if applicable)

 

4,923,482

 

 

 

40,673,566

 

 

 

Unlisted options exercisable at $0.60 on or before 15 April 2019

 

 

Unlisted options with a nil exercise price and expiring on 16 November 2021

 

3,015,000

 

Unlisted options exercisable at $0.457 on or before 30 January 2023, vesting 12 months from the date of issue and subject to a restriction period to 30 January 2022;

 

3,015,000

 

Unlisted options exercisable at $0.707 on or before 30 January 2023 vesting 24 months from the date of issue and subject to a restriction period to 30 January 2022;

 

3,015,000

 

Unlisted options exercisable at $0.907 on or before 30 January 2023 vesting 36 months from the date of issue and subject to a restriction period to 30 January 2022;

 

 

3,050,000

 

Performance Rights vesting in various tranches expiring 21 February 2022

 

10

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

The Company does not have a dividend policy.

 

Part 2 ‑ Bonus issue or pro rata issue

 

11

Is security holder approval required?

N/A

 

12

Is the issue renounceable or non-renounceable?

N/A

 

13

Ratio in which the +securities will be offered

N/A

 

14

+Class of +securities to which the offer relates

N/A

 

15

+Record date to determine entitlements

N/A

 

16

Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?

N/A

 

17

Policy for deciding entitlements in relation to fractions

N/A

 

18

Names of countries in which the entity has security holders who will not be sent new offer documents

Note: Security holders must be told how their entitlements are to be dealt with.

Cross reference: rule 7.7.

N/A

 

19

Closing date for receipt of acceptances or renunciations

N/A

20

Names of any underwriters

N/A

 

21

Amount of any underwriting fee or commission

N/A

 

22

Names of any brokers to the issue

N/A

 

23

Fee or commission payable to the broker to the issue

N/A

 

24

Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of security holders

N/A

 

25

If the issue is contingent on +security holders' approval, the date of the meeting

N/A

 

26

Date entitlement and acceptance form and will be sent to persons entitled

N/A

 

27

If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders

N/A

 

28

Date rights trading will begin (if applicable)

N/A

 

29

Date rights trading will end (if applicable)

N/A

 

30

How do security holders sell their entitlements in full through a broker?

N/A

 

31

How do security holders sell part of their entitlements through a broker and accept for the balance?

N/A

 

32

How do security holders dispose of their entitlements (except by sale through a broker)?

N/A

 

33

+Issue date

N/A

 

 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

 

34

Type of securities

(tick one)

 

(a)

X

+Securities described in Part 1

(b)

All other +securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

 

 

Entities that have ticked box 34(a)

 Additional securities forming a new class of securities

 

Tick to indicate you are providing the information or documents

 

35

If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders

 

36

If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over

 

37

A copy of any trust deed for the additional +securities

 

Entities that have ticked box 34(b)

 

38

Number of +securities for which +quotation is sought

 

N/A

 

 

 

39

Class of +securities for which quotation is sought

 

N/A

 

 

 

40

Do the +securities rank equally in all respects from the +issue with an existing +class of quoted +securities?

 

If the additional +securities do not rank equally, please state:

· the date from which they do

· the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

· the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

N/A

 

 

 

41

Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

 

(if issued upon conversion of another +security, clearly identify that other +security)

 

N/A

 

 

 

Number

+Class

42

Number and +class of all +securities quoted on ASX (including the +securities in clause 38)

 

 

 

N/A

 

 

 

Quotation agreement

 

1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

 

2 We warrant the following to ASX.

 

· The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

 

· There is no reason why those +securities should not be granted +quotation.

 

· An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 

· Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

 

· If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

 

3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

 

4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

 

 

MARK CLEMENTS

Company Secretary

27 February 2019

== == == == ==

 

Appendix 3B - Annexure 1

 

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

 

Part 1

 

Rule 7.1 - Issues exceeding 15% of capital

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

Insert number of fully paid +ordinary securities on issue 12 months before the +issue date or date of agreement to issue

189,675,326

 

Add the following:

• Number of fully paid +ordinary securities issued in that 12-month period under an exception in rule 7.2

• Number of fully paid +ordinary securities issued in that 12-month period with shareholder approval

 

 

(i) 12 March 2018 Issue of Shares following exercise of options

 

180,448

 

(ii) 12 March 2018 Issue Share pursuant to a placement

 

25,531,915

 

(iii) 14 March 2018 Issue of Shares following exercise of options

 

1,019,119

 

(iv) 9 April 2018 Issue of Shares pursuant to the non-renounceable pro rata entitlement offer

 

13,450,429

 

(v) 9 April 2018 Issue of Shares following exercise of options

 

720,483

 

(vi) 20 April 2018 Issue of Shares following exercise of options

 

284,146

(vii) 26 April 2018 Issue of Shares following exercise of options

 

40,952

 

(viii) 30 April 2018 Issue of Shares following exercise of options

 

211,835

(ix) 1 May 2018 Issue of Shares following exercise of options

 

61,619

(x) 2 May 2018 Issue of Shares following exercise of options

 

2,000

(xi) 16 November 2018 Issue of Shares

 

17,090,000

(xii) 30 January 2019 Issue of Shares

423,069

(xiii) 27 February 2019 Issue of Shares pursuant to non-renounceable entitlement offer

 

21,353,317

 

Number of partly paid +ordinary securities that became fully paid in that 12-month period

Note:

• Include only ordinary securities here - other classes of equity securities cannot be added

• Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

• It may be useful to set out issues of securities on different dates as separate line items

(i) Subtract the number of fully paid +ordinary securities cancelled during that 12-month period

Nil

"A"

270,044,658

 

 

 

Step 2: Calculate 15% of "A"

 

"B"

0.15

[Note: this value cannot be changed]

Multiply "A" by 0.15

40,506,698

 

Step 3: Calculate "C", the amount of placement capacity under rule 7.1 that has already been used

Insert number of +equity securities issued or agreed to be issued in that 12-month period not counting those issued:

• Under an exception in rule 7.2

• Under rule 7.1A

• With security holder approval under rule 7.1 or rule 7.4

(i) 26 April 2018 Share Issue

(ii) 30 January 2019 Issue of Shares pursuant to a placement

Note:

• This applies to equity securities, unless specifically excluded - not just ordinary securities

• Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

• It may be useful to set out issues of securities on different dates as separate line items

 

 

304,348

33,333,333

 

"C"

33,637,681

 

Step 4: Subtract "C" from ["A" x "B"] to calculate remaining placement capacity under rule 7.1

"A" x 0.15

Note: number must be same as shown in Step 2

40,506,698

 

Subtract "C"

Note: number must be same as shown in Step 3

33,637,681

Total ["A" x 0.15] - "C"

6,869,017

 

 [Note: this is the remaining placement capacity under rule 7.1]

 

Part 2

 

Rule 7.1A - Additional placement capacity for eligible entities

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

"A"

Note: number must be same as shown in Step 1 of Part 1

270,044,658

 

Step 2: Calculate 10% of "A"

"D"

0.10

 

Note: this value cannot be changed

Multiply "A" by 0.10

27,004,465

 

Step 3: Calculate "E", the amount of placement capacity under rule 7.1A that has already been used

Insert number of +equity securities issued or agreed to be issued in that 12-month period under rule 7.1A

Notes:

• This applies to equity securities - not just ordinary securities

• Include here - if applicable - the securities the subject of the Appendix 3B to which this form is annexed

• Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

• It may be useful to set out issues of securities on different dates as separate line items

 

"E"

-

Step 4: Subtract "E" from ["A" x "D"] to calculate remaining placement capacity under rule 7.1A

"A" x 0.10

Note: number must be same as shown in Step 2

27,004,465

 

Subtract "E"

Note: number must be same as shown in Step 3

-

Total ["A" x 0.10] - "E"

27,004,465

Note: this is the remaining placement capacity under rule 7.1A

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCPGURWPUPBUBM
Date   Source Headline
25th Jun 20197:00 amRNSSandfire to Acquire MOD Resources
3rd Jun 20198:52 amRNSUpdate on Issue of Equity and TVR and Capital
30th May 20199:26 amRNSAppendix 3Y
30th May 20199:25 amRNSAppendix 3Y
30th May 20199:22 amRNSAppendix 3Y
30th May 20199:17 amRNSAppendix 3B
29th May 20199:41 amRNSResults of Annual General Meeting
29th May 20197:00 amRNSChairman Address for the 2018 AGM
7th May 20197:04 amRNSMOD Progresses Growth Strategy
1st May 20197:00 amRNSUpdate on Issue of Equity and TVR and Capital
29th Apr 20197:19 amRNST3 Resource Infill Drilling Results
26th Apr 20199:04 amRNSQuarterly Activities Report
26th Apr 20199:02 amRNSQuarterly Cashflow Report
26th Apr 20199:01 amRNSNotice of Annual General Meeting/ Proxy Form
23rd Apr 20193:33 pmRNSUpdate on Issue of Equity and TVR and Capital
16th Apr 20197:21 amRNSAppendix 3Y
16th Apr 20197:17 amRNSAppendix 3Y
16th Apr 20197:15 amRNSAppendix 3Y
16th Apr 20197:14 amRNSSection 708A Notice
16th Apr 20197:12 amRNSAppendix 3Y
16th Apr 20197:09 amRNSAppendix 3B
3rd Apr 20197:00 amRNSNotice of Substantial Shareholder
1st Apr 201910:20 amRNSUpdate on Issue of Equity and TVR and Capital
28th Mar 20197:02 amRNSAnnual Report
28th Mar 20197:01 amRNSAppendix 4G
28th Mar 20197:00 amRNST3 Feasibility Study
25th Mar 20197:06 amRNS61% Increase in T3 Open Pit Ore Reserve to 34.4Mt
15th Mar 201911:37 amRNSPublication of a Prospectus
12th Mar 20197:02 amRNSStrong T3 Infill Drilling Results
8th Mar 201912:51 pmRNSPublication of Prospectus
1st Mar 20197:09 amRNSUpdate on Issue of Equity and TVR and Capital
27th Feb 20199:59 amRNSAppendix 3Y
27th Feb 20199:56 amRNSAppendix 3Y
27th Feb 20199:54 amRNSAppendix 3Y
27th Feb 20199:52 amRNSAppendix 3Y
27th Feb 20199:45 amRNSAppendix 708A
27th Feb 20199:41 amRNSAppendix 3B
25th Feb 20197:03 amRNSPresentation - BMO Global Metals & Mining
25th Feb 20197:03 amRNSEntitlement Offer Shortfall Notice
20th Feb 20198:42 amRNSWins Prestigious Craig Oliver Award
15th Feb 20198:44 amRNSUpdate on Issue of Equity and TVR and Capital
6th Feb 20197:35 amRNSDispatch of Entitlement Offer Document
4th Feb 20198:09 amRNSPresentation - 121 Mining Conference
31st Jan 201910:38 amRNSLetter to Eligible Shareholders
31st Jan 201910:34 amRNSLetter to Ineligible Shareholders
31st Jan 201910:29 amRNSAppendix 3Y
31st Jan 201910:28 amRNSAppendix 3Y
31st Jan 201910:28 amRNSAppendix 3Y
31st Jan 201910:28 amRNSAppendix 3Y
31st Jan 201910:28 amRNSAppendix 3Y

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.